The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a series of new rules from the Centers for Medicare & Medicaid Services (CMS). Earlier ...
Heart Failure
This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).
-
-
Aug. 31, 2026 — A new heart failure (HF) treatment effect calculator could help overcome one of the largest barriers to effective heart failure care by predicting the expected effects of treatment on ...
-
Aug. 28, 2026 — At ESC Congress in Munich, the European Society of Cardiology released its first updated heart failure guidelines (with a corresponding summary table) since 2021, and two of Abbott's ...
-
Study: Artery Damage in Adults in Their 20s Highlights Need for Early Cardiovascular Risk AssessmentAug. 20, 2026 — A new study found that nearly 8 out of 10 young adult participants, average age 23 years, had cardiovascular-kidney-metabolic syndrome (CKM syndrome), according to new independent ...
Feature | Heart Failure | Kyle Hardner
The shift toward steering appropriate cardiovascular cases to outpatient settings is gaining momentum, driven by a ...
September 11, 2026
Sept. 9, 2026— Atman Health has been selected by the Advanced Research Projects Agency for Health (ARPA-H) to develop an ...
September 11, 2026
Aug. 31, 2026 — Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk ...
September 02, 2026Sponsored Content
Feature | Cardiac Imaging
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026
Aug. 31, 2026 — A new heart failure (HF) treatment effect calculator could help overcome one of the largest barriers to ...
August 31, 2026
Aug. 28, 2026 — At ESC Congress in Munich, the European Society of Cardiology released its first updated heart failure ...
August 28, 2026
Study: Artery Damage in Adults in Their 20s Highlights Need for Early Cardiovascular Risk Assessment
Aug. 20, 2026 — A new study found that nearly 8 out of 10 young adult participants, average age 23 years, had cardiovasc ...
August 21, 2026Sponsored Content
Blog | Artificial Intelligence
New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...
October 10, 2022
Aug. 20, 2026 — Bayer has announced that 11 oral presentations across its cardiovascular, kidney, and secondary stroke ...
August 20, 2026
Aug. 18, 2026 — Murj, a cardiac device management software and services company, has released of its Murj Remote Patient ...
August 19, 2026
July 28, 2026 — Abbott has initiated the Treat TR study, a post-market study of the company’s TriClip transcatheter ...
July 29, 2026
July 24, 2026 — MannKind Corp. recently announced that the U.S. Food and Drug Administration (FDA) has approved Furoscix ...
July 28, 2026
July 21, 2026 — Women who experience pregnancy complications face an increased risk of developing peripheral artery ...
July 22, 2026
July 22, 2026
July 20, 2026 — Young women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovarian ...
July 21, 2026
July 16, 2026 — Merck has received U.S. Food and Drug Administration (FDA) approval for Lipfendra (enlicitide) tablets ...
July 16, 2026
July 14, 2026 — Atrium Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared its ...
July 14, 2026